Other liabilities |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2026 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Other liabilities. | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Other liabilities | 22.Other liabilities
The decrease by €707,000 in other liabilities as at June 30, 2026, compared to December 31, 2025, is mainly due to a decrease by €1.0 million in payroll related liabilities. The decrease is partly offset by an increase of €0.6 million in accrued expenses and €203,000 in other. As at June 30, 2026, Other mainly consists of an outstanding liability related to the continued development of the Company’s strategic R&D project. |
||||||||||||||||||||||||||||||||||||||||||||||||||